Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Kromek Group plc ( (GB:KMK) ) is now available.
Kromek Group plc announced it will release its interim results for the six months ended 31 October 2025 on 20 January 2026. The company will host an online Q&A session for investors on 26 January 2026, providing an opportunity for stakeholders to engage with the CEO and CFO. This announcement highlights Kromek’s commitment to transparency and investor engagement, potentially strengthening its market position.
The most recent analyst rating on (GB:KMK) stock is a Buy with a £7.00 price target. To see the full list of analyst forecasts on Kromek Group plc stock, see the GB:KMK Stock Forecast page.
Spark’s Take on GB:KMK Stock
According to Spark, TipRanks’ AI Analyst, GB:KMK is a Outperform.
Kromek Group plc’s overall stock score of 72 reflects its strong financial performance and positive corporate events, which are the most significant factors. The technical analysis presents a mixed picture, while the valuation suggests potential undervaluation. The absence of earnings call data does not impact the score significantly.
To see Spark’s full report on GB:KMK stock, click here.
More about Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions, focusing on advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, with operations in the UK and US, Kromek serves medical, security, industrial, and homeland defense markets, providing detector components and nuclear radiation detection solutions.
Average Trading Volume: 2,085,651
Technical Sentiment Signal: Buy
Current Market Cap: £50.44M
For detailed information about KMK stock, go to TipRanks’ Stock Analysis page.